RecruitingNCT06827314

Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

500 participants

Start Date

Dec 6, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to understand and describe the epidemiology of cardiogenic shock in Emilia Romagna with a specific focus on outcome stratified by aetiologies, sex and age. The main outcomes are: * Incidence of cardiogenic shock (CS) over the total CICU admissions, CS-related in-hospital mortality and length of hospitalization, stratified by aetiologies, sex and age * Epidemiology of patients admitted with CS, regarding age, gender, etiology and modality of presentation (acute or acute on chronic), echocardiographic and haemodynamic data, treatment strategy with inotropes and/or short-term MCS, cardiac arrest. This is an observational study without intervention. Patients will be treated according to current clinical practice, according to physician judgment and data sheets of each drug used according to clinical practice.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is observing how doctors treat patients admitted to cardiac intensive care units with cardiogenic shock — a life-threatening condition where the heart suddenly cannot pump enough blood to the body. The study looks at both medication-based and device-based support approaches used in a regional hospital network. **You may be eligible if...** - You are 18 years or older - You have been admitted to a participating cardiac intensive care unit - You are suspected of having cardiogenic shock at a moderate to severe level (classified as stage C, D, or E on a standard medical scale) - You or a representative can provide signed informed consent **You may NOT be eligible if...** - Your shock developed after heart surgery (post-cardiotomy shock) - You have significant injuries to multiple body systems (polytrauma) - You have a serious neurological injury Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06827314


Related Trials